Read our Policy on Clinical Trial Transparency & Disclosure
Teva’s Commitment to Clinical Trial Transparency
Teva believes clinical trial participants and the public should have access to clinical trial results to promote data transparency and support the advancement of medical understanding. Data from our studies are handled with care to ensure patient safety, data quality, and corporate integrity. Our commitment to data sharing is aligned with global pharmaceutical industry associations and related laws. Teva will ensure results of clinical trials are made publicly available per regulatory guidelines and will provide free access to this information online, regardless of whether results are neutral, positive, or negative.
In an effort to enhance transparency, Teva is committed to sharing data with qualified researchers. This advances medical knowledge and scientific discovery, which can help improve public health. Teva understands the importance of protecting patient privacy and preserving regulatory authority, while maintaining incentives for those who generate data to conduct new research.
Teva provides free access to clinical study plans and results online on several global, publically-accessible Clinical Trial Registries. To access information on Teva clinical trials, please visit our Find a Trial page.
Teva’s Policy on Clinical Trial Transparency & Disclosure describes key mechanisms through which we comply with relevant FDA and EMA regulations.